1. Home
  2. IMKTA vs PHVS Comparison

IMKTA vs PHVS Comparison

Compare IMKTA & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMKTA
  • PHVS
  • Stock Information
  • Founded
  • IMKTA 1963
  • PHVS 2015
  • Country
  • IMKTA United States
  • PHVS Switzerland
  • Employees
  • IMKTA N/A
  • PHVS N/A
  • Industry
  • IMKTA Food Chains
  • PHVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • IMKTA Consumer Staples
  • PHVS Health Care
  • Exchange
  • IMKTA Nasdaq
  • PHVS Nasdaq
  • Market Cap
  • IMKTA 1.3B
  • PHVS 1.3B
  • IPO Year
  • IMKTA N/A
  • PHVS 2021
  • Fundamental
  • Price
  • IMKTA $70.62
  • PHVS $24.54
  • Analyst Decision
  • IMKTA
  • PHVS Strong Buy
  • Analyst Count
  • IMKTA 0
  • PHVS 5
  • Target Price
  • IMKTA N/A
  • PHVS $35.60
  • AVG Volume (30 Days)
  • IMKTA 104.9K
  • PHVS 144.5K
  • Earning Date
  • IMKTA 08-07-2025
  • PHVS 11-12-2025
  • Dividend Yield
  • IMKTA 0.93%
  • PHVS N/A
  • EPS Growth
  • IMKTA N/A
  • PHVS N/A
  • EPS
  • IMKTA 2.97
  • PHVS N/A
  • Revenue
  • IMKTA $5,363,138,171.00
  • PHVS N/A
  • Revenue This Year
  • IMKTA N/A
  • PHVS N/A
  • Revenue Next Year
  • IMKTA N/A
  • PHVS N/A
  • P/E Ratio
  • IMKTA $23.63
  • PHVS N/A
  • Revenue Growth
  • IMKTA N/A
  • PHVS N/A
  • 52 Week Low
  • IMKTA $58.92
  • PHVS $11.51
  • 52 Week High
  • IMKTA $75.63
  • PHVS $26.33
  • Technical
  • Relative Strength Index (RSI)
  • IMKTA 63.41
  • PHVS 60.91
  • Support Level
  • IMKTA $68.19
  • PHVS $23.20
  • Resistance Level
  • IMKTA $71.88
  • PHVS $24.02
  • Average True Range (ATR)
  • IMKTA 1.58
  • PHVS 1.37
  • MACD
  • IMKTA 0.01
  • PHVS 0.08
  • Stochastic Oscillator
  • IMKTA 74.29
  • PHVS 84.66

About IMKTA Ingles Markets Incorporated

Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

Share on Social Networks: